Tert-butyl N-[5-[4-(2-amino-2,4-dimethylpentoxy)-3-chlorophenyl]pyridazin-3-yl]-N-methoxycarbonylcarbamate
C24H33ClN4O5 — CID 175068737
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[5-[4-(2-amino-2,4-dimethylpentoxy)-3-chlorophenyl]pyridazin-3-yl]-N-methoxycarbonylcarbamate
Tert-butyl N-[5-[4-(2-amino-2,4-dimethylpentoxy)-3-chlorophenyl]pyridazin-3-yl]-N-methoxycarbonylcarbamate (PubChem CID 175068737) has the molecular formula C24H33ClN4O5 and a molecular weight of 493.00 g/mol. Its IUPAC name is tert-butyl N-[5-[4-(2-amino-2,4-dimethylpentoxy)-3-chlorophenyl]pyridazin-3-yl]-N-methoxycarbonylcarbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[5-[4-(2-amino-2,4-dimethylpentoxy)-3-chlorophenyl]pyridazin-3-yl]-N-methoxycarbonylcarbamate |
|---|---|
| PubChem CID | 175068737 |
| Molecular Formula | C24H33ClN4O5 |
| Molecular Weight | 493.00 g/mol |
| Exact Mass | 492.21 |
| IUPAC Name | tert-butyl N-[5-[4-(2-amino-2,4-dimethylpentoxy)-3-chlorophenyl]pyridazin-3-yl]-N-methoxycarbonylcarbamate |
| SMILES | COC(=O)N(C(=O)OC(C)(C)C)c1cc(-c2ccc(OCC(C)(N)CC(C)C)c(Cl)c2)cnn1 |
| InChI | InChI=1S/C24H33ClN4O5/c1-15(2)12-24(6,26)14-33-19-9-8-16(10-18(19)25)17-11-20(28-27-13-17)29(21(30)32-7)22(31)34-23(3,4)5/h8-11,13,15H,12,14,26H2,1-7H3 |
| InChIKey | BYORLBYWJKEDAT-UHFFFAOYSA-N |
| XLogP | 5.45 |
| TPSA | 116.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 493.00 |
| LogP ≤ 5 | 5.45 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175068737 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.